Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein D-like pseudogene 3 (HNRNPDLP3)
- Target
- HNRNPDLP3
- Molecular classification
- Other (pseudogene)
01
Overview
HNRNPDLP3 is classified as a pseudogene of the heterogeneous nuclear ribonucleoprotein D-like (HNRNPDL) family[4][6]. Unlike its protein-coding relatives, such as HNRNPDL, HNRNPDLP3 does not produce a functional protein and is thus not involved in known biological processes, cellular pathways, or diseases. It does not possess therapeutic relevance, and there are no current drugs, biomarkers, or safety concerns associated with the pseudogene itself. If your inquiry was aimed at a druggable or functionally active target, there is a likely error—this is a pseudogene (non-coding/non-functional), not an active receptor, enzyme, or protein[4][6]. The protein-coding HNRNPDL gene encodes an RNA-binding protein involved in mRNA metabolism, splicing, and is linked to diseases such as limb-girdle muscular dystrophy[1][5][2]. Pseudogenes like HNRNPDLP3 can sometimes be transcribed or have regulatory roles, but there is no known evidence for HNRNPDLP3 as a functional or drug target.
- Other names
- HNRNPDLP3heterogeneous nuclear ribonucleoprotein D-like pseudogene 3
Beyond the preview
Go deeper on Heterogeneous nuclear ribonucleoprotein D-like pseudogene 3 (HNRNPDLP3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein D-like pseudogene 3 (HNRNPDLP3).